Literature DB >> 31530419

The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models.

Omer Aydin1, Parwathy Chandran2, Rebecca R Lorsung2, Gadi Cohen2, Scott R Burks2, Joseph A Frank3.   

Abstract

Non-ablative pulsed focused ultrasound (pFUS) targets non-thermal forces that activate local molecular and cellular immune responses. Optimal parameters to stimulate immunotherapeutic tumor microenvironments (TME) and responses in different tumor types remain uninvestigated. Flank B16 murine melanoma and 4T1 breast tumors received 1 MHz pFUS at 1-8 MPa peak negative pressures (PNP) and were analyzed 24 hr post-sonication. Necrosis or hemorrhage were unaltered in both tumors, but pFUS induced DNA strand breaks in tumor cells at PNP ≥6 MPa. pFUS at >4 MPa suppressed anti-inflammatory cytokines in B16 tumors. pFUS to 4T1 tumors decreased anti-inflammatory cytokines and increased pro-inflammatory cytokines and cell adhesion molecules. pFUS at 6 MPa increased calreticulin and alterations in check-point proteins along with tumoral and splenic immune cell changes that could be consistent with a shift towards an anti-TME. pFUS-induced TME alterations shows promise in generating anti-tumor immune responses, but non-uniform responses between tumor types require additional investigation to assess pFUS as a suitable anti-tumor therapy. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer; Flow cytometry; Focused ultrasound; Melanoma; Proteomics; Tumor microenvironment

Mesh:

Year:  2019        PMID: 31530419      PMCID: PMC7456468          DOI: 10.1016/j.ultrasmedbio.2019.08.014

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  66 in total

1.  Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses.

Authors:  Jian Deng; Ying Zhang; Jun Feng; Feng Wu
Journal:  Ultrasound Med Biol       Date:  2010-03       Impact factor: 2.998

2.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

Review 3.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

4.  Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.

Authors:  Zhong-Lin Xu; Xue-Qiang Zhu; Pei Lu; Qiang Zhou; Jun Zhang; Feng Wu
Journal:  Ultrasound Med Biol       Date:  2008-10-31       Impact factor: 2.998

Review 5.  Implications of the tumor immune microenvironment for staging and therapeutics.

Authors:  Janis M Taube; Jérôme Galon; Lynette M Sholl; Scott J Rodig; Tricia R Cottrell; Nicolas A Giraldo; Alexander S Baras; Sanjay S Patel; Robert A Anders; David L Rimm; Ashley Cimino-Mathews
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

6.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

7.  NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells.

Authors:  Won Jong Jin; Bongjun Kim; Darong Kim; Hea-Young Park Choo; Hong-Hee Kim; Hyunil Ha; Zang Hee Lee
Journal:  Exp Mol Med       Date:  2017-02-17       Impact factor: 8.718

Review 8.  High-intensity focused ultrasound therapy: an overview for radiologists.

Authors:  Young-sun Kim; Hyunchul Rhim; Min Joo Choi; Hyo Keun Lim; Dongil Choi
Journal:  Korean J Radiol       Date:  2008 Jul-Aug       Impact factor: 3.500

9.  Immune microenvironment in tumor progression: characteristics and challenges for therapy.

Authors:  Valerie Chew; Han Chong Toh; Jean-Pierre Abastado
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

10.  MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain.

Authors:  Zsofia I Kovacs; Tsang-Wei Tu; Maggie Sundby; Farhan Qureshi; Bobbi K Lewis; Neekita Jikaria; Scott R Burks; Joseph A Frank
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

View more
  7 in total

Review 1.  Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.

Authors:  Jordan B Joiner; Yuliya Pylayeva-Gupta; Paul A Dayton
Journal:  J Immunol       Date:  2020-11-01       Impact factor: 5.422

Review 2.  Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review.

Authors:  Alissa Hendricks-Wenger; Lauren Arnold; Jessica Gannon; Alex Simon; Neha Singh; Hannah Sheppard; Margaret A Nagai-Singer; Khan Mohammad Imran; Kiho Lee; Sherrie Clark-Deener; Christopher Byron; Michael R Edwards; Martha M Larson; John H Rossmeisl; Sheryl L Coutermarsh-Ott; Kristin Eden; Nikolaos Dervisis; Shawna Klahn; Joanne Tuohy; Irving Coy Allen; Eli Vlaisavljevich
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-12-31       Impact factor: 3.267

3.  The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response.

Authors:  Gadi Cohen; Parwathy Chandran; Rebecca M Lorsung; Lauren E Tomlinson; Maggie Sundby; Scott R Burks; Joseph A Frank
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

4.  Cytosolic Ca2+ transients during pulsed focused ultrasound generate reactive oxygen species and cause DNA damage in tumor cells.

Authors:  Robert B Rosenblatt; Joseph A Frank; Scott R Burks
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

5.  Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model.

Authors:  Jia-Ling Ruan; Richard J Browning; Yesna O Yildiz; Michael Gray; Luca Bau; Sukanta Kamila; James Thompson; Amy Elliott; Sean Smart; Anthony P McHale; John F Callan; Borivoj Vojnovic; Eleanor Stride; Anne E Kiltie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-04-01       Impact factor: 7.038

6.  Triple-combination therapy assisted with ultrasound-active gold nanoparticles and ultrasound therapy against 3D cisplatin-resistant ovarian cancer model.

Authors:  Bilgi Kip; Cansu Umran Tunc; Omer Aydin
Journal:  Ultrason Sonochem       Date:  2021-12-29       Impact factor: 7.491

Review 7.  Latest Advances in the Use of Therapeutic Focused Ultrasound in the Treatment of Pancreatic Cancer.

Authors:  Petros X E Mouratidis; Gail Ter Haar
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.